ondansetron has been researched along with Peripheral Nerve Diseases in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to examine whether the intensity of dynamic mechanical allodynia and spontaneous ongoing pain in patients with neuropathic pain associated with peripheral neuropathy was influenced by an intravenous infusion of the 5HT3-antagonist, ondansetron." | 9.15 | Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy. ( Hansson, P; Leffler, AS; Tuveson, B, 2011) |
| "The aim of this study was to examine whether the intensity of dynamic mechanical allodynia and spontaneous ongoing pain in patients with neuropathic pain associated with peripheral neuropathy was influenced by an intravenous infusion of the 5HT3-antagonist, ondansetron." | 5.15 | Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy. ( Hansson, P; Leffler, AS; Tuveson, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagalajev, B | 1 |
| Bourbia, N | 1 |
| Beloushko, E | 1 |
| Wei, H | 1 |
| Pertovaara, A | 1 |
| Tuveson, B | 1 |
| Leffler, AS | 1 |
| Hansson, P | 1 |
1 trial available for ondansetron and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Ondansetron, a 5HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy.
Topics: Adult; Analysis of Variance; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Hypera | 2011 |
1 other study available for ondansetron and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Bidirectional amygdaloid control of neuropathic hypersensitivity mediated by descending serotonergic pathways acting on spinal 5-HT3 and 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amygdala; Animals; Dizocilpine Maleate; Glutamic Acid; Male; | 2015 |